FindTrial
Sign In

Comparison of therapeutic effects of different treatment methods for distant lymph node metastasis in stage IVB ovarian cancer: a multicenter, retrospective study

Comparison of therapeutic effects of different treatment methods for distant lymph node metastasis in stage IVB ovarian cancer: a multicenter, retrospective study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091655
Enrollment
Unknown
Registered
2024-10-31
Start date
2024-06-01
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IVB stage ovarian cancer with distant lymph node metastasis

Interventions

PDS group:NA
PDS+LND group:NA
NACT+IDS group:NA

Sponsors

Zhejiang Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Age 18 to 75 years; 2.ECOG score 0-1; 3.Newly diagnosed FIGO stage (2014 edition) III/IV high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer; 4.Any distant lymph node metastasis outside the abdominal cavity diagnosed by imaging or pathology; 5.Patients who underwent primary debulking surgery or interval debulking surgery; 6.Patients who received the standard first-line adjuvant treatment;

Exclusion criteria

Exclusion criteria: 1.History of other malignant tumors; 2.Any distant metastases to bone, thorax and viscera; 3.Unable to obtain complete follow-up data;

Design outcomes

Primary

MeasureTime frame
Progression free survival (PFS);—

Secondary

MeasureTime frame
Overall survival (OS);Perioperative complications;Prognostic factors;Clinical characteristics of first recurrence after treatment;—

Countries

China

Contacts

Public ContactQiang Wen

Zhejiang Cancer Hospital

windstrong2007@163.com+86 571 88128131

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026